Autres langues Caplin Point Laboratories Limited

Actions

CAPLIPOINT

INE475E01026

Marché Fermé - Bombay S.E. Autres places de cotation 12:00:47 10/05/2024			Varia. 5j.	Varia. 1 janv.
1 281 ^INR	+0,52%		-3,78%	-5,56%

06/05	Caplin Point Laboratories obtient l'approbation de l'organisme colombien de réglementation des médicaments pour son unité de gélules molles en Inde	MT
28/03	Caplin Point reçoit le feu vert de la FDA pour un médicament destiné au traitement des yeux	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Caplin Point Laboratories Gets Colombian Drug Regulator's Approval for Soft Gel Capsules Unit in India	06/05
Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution	16/04
Caplin Point Unit Receives US FDA Nod for Eye Treatment Medication	28/03
Caplin Steriles Limited, A Subsidiary of Caplin Point Laboratories Limited Gets USFDA Approval for Ketorolac Tromethamine Ophthalmic Solution	28/03
Caplin Point Laboratories Arm Starts Operations of Oncology Facility at Kakkalur, India	27/03
Caplin One Labs Limited, a Wholly Owned Subsidiary of Caplin Point Laboratories Limited Successfully Completes New Oncology (Anti-Cancer) Facility, Commences Operations	27/03
Caplin Point Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	09/02
Caplin Point Laboratories to Invest INR7 Billion in Tamil Nadu, India	08/01
Caplin Point Unit Gets US FDA Final Approval for Generic Ear Infection Drug	08/01
Caplin Point Laboratories Limited Announces Resignation of Hero Velladurai as President, R&D	14/12
Caplin Point Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	09/11
Caplin Point Laboratories Limited Approves Final Dividend for the Year Ended March 31, 2023	22/09/23
Caplin Point Unit's Injectable and Ophthalmic Plant in India Gets VAI Classification from US FDA	04/09/23
Caplin Point Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	07/08/23
Caplin Point Laboratories Limited Recommends Final Dividend for the Financial Year Ended March 31, 2023	07/08/23
Caplin Point Laboratories to Incorporate Step-Down Subsidiary in US	03/08/23
Caplin Point Unit Gets US FDA Nod for Muscle Relaxant	12/06/23
Caplin Steriles Limited Gets United States Food and Drug Administration Approval for Cisatracurium Besylate Injection USP	12/06/23
Caplin Point Gets Four Observations from US FDA After Inspection of Injectable Unit at Gummidipoondi, India	01/06/23
Caplin Point Laboratories Limited Approves Interim Dividend for the Financial Year 2022-23	27/05/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Caplin Point Laboratories Limited

Actions

CAPLIPOINT

INE475E01026

Autres langues

Filtres